AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Women's Sexual Dysfunction Programs Expanded.
2001 JAN 11 - (NewsRx.com) -- Cellegy Pharmaceuticals, Inc. (CLGY), San Francisco, California, announced that it has initiated an expanded Phase I/II clinical trial of Tostrelle, its transdermal testosterone gel product for female sexual dysfunction.
Testosterone deficiency in women frequently leads to diminished libido, and decreased muscle/bone mass and energy level.
Additionally, Cellegy announced it is sponsoring a collaborative research program focusing on a specific female sexual disorder at the University of California, Los Angeles, Medical Center. The program will be conducted by Jennifer Berman, MD.
Cellegy is currently enrolling surgically-induced menopausal women on estrogen replacement therapy for the expanded Phase I/II study in the United Kingdom. This study is designed to ...
- Endocrine Society Calls for Clinical Guidelines on Androgens for Women;...
- Press release article from: PR Newswire December 2, 2004 700+ words
...of androgens in women/female sexual dysfunction. The organization also...growing recognition of female sexual dysfunction as well as the increase...guidelines in 2005." Female Sexual Dysfunction Female sexual dysfunction...
- Research from A. Manolis and co-researchers in the area of female sexual...
- Magazine article from: Women's Health Weekly November 20, 2008 700+ words
...dysfunction, as male and female sexual dysfunction is more prevalent in hypertensive...antihypertensive therapy. Female sexual dysfunction, although more frequent...colleagues, (see also Female Sexual Dysfunction Therapy). The researchers...
- New Female Sexual Dysfunction Patents Granted to VIVUS; Patents Support and...
- Press release article from: Business Wire July 15, 2003 700+ words
...relating to the treatment of female sexual dysfunction (FSD). The patents...more than one type of female sexual dysfunction." More on the Patents...Agent in the Treatment of Female Sexual Dysfunction," encompasses not only...
- Examine Approaches to Female Sexual Dysfunction Treatment in the Pipeline and...
- Press release article from: Business Wire November 15, 2005 700+ words
...researchandmarkets.com/reports/c27816) has announced the addition of Major Milestones: Female Sexual Dysfunction to their offering. Female sexual dysfunction affects an estimated 84 million women across the seven major pharmaceutical markets and...
- Hypertension linked to Female Sexual Dysfunction.
- News wire article from: PTI - The Press Trust of India Ltd. May 20, 2006 700+ words
Hypertension linked to Female Sexual Dysfunction Houston, May 20 (PTI): Female sexual dysfunction is more prevalent in women with hypertension compared to those with normal blood pressure...
- VIVUS Awarded Patent for Treatment of Female Sexual Dysfunction Using...
- Press release article from: Business Wire October 22, 2002 700+ words
...entitled "Treatment of Female Sexual Dysfunction Using Phosphodiesterase...for the treatment of Female Sexual Dysfunction (FSD). "This is a...future products to treat Female Sexual Dysfunction. We believe that local...
- VIVUS Awarded Patent for Treatment of Female Sexual Dysfunction With...
- Press release article from: Business Wire October 23, 2001 700+ words
...titled "Treatment of Female Sexual Dysfunction," by the U.S. Patent...for the treatment of female sexual dysfunction (FSD). One potential...protection in the area of female sexual dysfunction continues to be strengthened...
- Scientists at University of North Carolina target female sexual dysfunction.
- Magazine article from: Women's Health Weekly August 21, 2008 700+ words
...vulvovaginal atrophy and female sexual dysfunction is unclear. We investigated...Survey was used to define female sexual dysfunction. Sexual dysfunction subtypes...vulvovaginal atrophy and female sexual dysfunction. The prevalence of vulvovaginal...